About
ADVITOS GmbH is a medical technology company based in Munich, Germany, focused on developing advanced medical devices for multi-organ support in intensive care units. Their flagship product, the ADVOS multi, is a CE-certified therapy device that uniquely integrates support for the liver, lungs, and kidneys, along with blood pH correction, into a single system. This innovative device addresses the three main detoxification organs simultaneously, enhancing patient care in critical situations. Founded by Dr. Bernhard Kreymann, ADVITOS has evolved from its origins in liver support therapies to a comprehensive medical technology provider. The company employs around 55 people and has secured approximately $37.6 million in funding, including support from the European Union’s Horizon 2020 program. ADVITOS is dedicated to research, development, production, and clinical support, ensuring effective use of the ADVOS multi system in intensive care units. Their commitment to improving patient outcomes is reflected in their ongoing research and development efforts, aimed at establishing the ADVOS therapy as a new standard in intensive care medicine.
Technologies
Keywords
Company Information
-
Employees 56
-
Founded 1994
-
Total Funding $31725700
Location
1 Agnes-Pockels-Bogen, Muenchen, Bayern, Germany, 80992
